FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890762462> ?p ?o ?g. }

• W2890762462 endingPage "5149" @default.
• W2890762462 startingPage "5137" @default.
• W2890762462 abstract "Despite the success of immune checkpoint blockade against melanoma, many cold tumors like prostate cancer remain unresponsive. We found that hypoxic zones were prevalent across preclinical prostate cancer and resisted T cell infiltration even in the context of CTLA-4 and PD-1 blockade. We demonstrated that the hypoxia-activated prodrug TH-302 reduces or eliminates hypoxia in these tumors. Combination therapy with this hypoxia-prodrug and checkpoint blockade cooperated to cure more than 80% of tumors in the transgenic adenocarcinoma of the mouse prostate-derived (TRAMP-derived) TRAMP-C2 model. Immunofluorescence imaging showed that TH-302 drives an influx of T cells into hypoxic zones, which were expanded by checkpoint blockade. Further, combination therapy reduced myeloid-derived suppressor cell density by more than 50%, and durably reduced the capacity of the tumor to replenish the granulocytic subset. Spontaneous prostate tumors in TRAMP transgenic mice, which completely resist checkpoint blockade, showed minimal adenocarcinoma tumor burden at 36 weeks of age and no evidence of neuroendocrine tumors with combination therapy. Survival of Pb-Cre4, Ptenpc-/-Smad4pc-/- mice with aggressive prostate adenocarcinoma was also significantly extended by this combination of hypoxia-prodrug and checkpoint blockade. Hypoxia disruption and T cell checkpoint blockade may sensitize some of the most therapeutically resistant cancers to immunotherapy." @default.
• W2890762462 created "2018-09-27" @default.
• W2890762462 creator A5005203519 @default.
• W2890762462 creator A5005298592 @default.
• W2890762462 creator A5008753971 @default.
• W2890762462 creator A5015105154 @default.
• W2890762462 creator A5023083194 @default.
• W2890762462 creator A5024539248 @default.
• W2890762462 creator A5030756098 @default.
• W2890762462 creator A5034936114 @default.
• W2890762462 creator A5036532953 @default.
• W2890762462 creator A5050522406 @default.
• W2890762462 creator A5054336312 @default.
• W2890762462 creator A5056472340 @default.
• W2890762462 creator A5065861312 @default.
• W2890762462 creator A5066060808 @default.
• W2890762462 creator A5081616053 @default.
• W2890762462 creator A5083451488 @default.
• W2890762462 creator A5087385646 @default.
• W2890762462 creator A5089753814 @default.
• W2890762462 date "2018-10-15" @default.
• W2890762462 modified "2023-10-17" @default.
• W2890762462 title "Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy" @default.
• W2890762462 cites W1676754695 @default.
• W2890762462 cites W1927075449 @default.
• W2890762462 cites W1964636114 @default.
• W2890762462 cites W1979811833 @default.
• W2890762462 cites W1983517349 @default.
• W2890762462 cites W1987534017 @default.
• W2890762462 cites W1989792740 @default.
• W2890762462 cites W1991880013 @default.
• W2890762462 cites W1993869378 @default.
• W2890762462 cites W2024903578 @default.
• W2890762462 cites W2029206767 @default.
• W2890762462 cites W2044363258 @default.
• W2890762462 cites W2049491375 @default.
• W2890762462 cites W2070059266 @default.
• W2890762462 cites W2091041420 @default.
• W2890762462 cites W2091935484 @default.
• W2890762462 cites W2109424201 @default.
• W2890762462 cites W2112601576 @default.
• W2890762462 cites W2120467578 @default.
• W2890762462 cites W2122158568 @default.
• W2890762462 cites W2122291110 @default.
• W2890762462 cites W2125200489 @default.
• W2890762462 cites W2131874142 @default.
• W2890762462 cites W2132667524 @default.
• W2890762462 cites W2134053452 @default.
• W2890762462 cites W2143163879 @default.
• W2890762462 cites W2155959680 @default.
• W2890762462 cites W2157737696 @default.
• W2890762462 cites W2164942212 @default.
• W2890762462 cites W2165036434 @default.
• W2890762462 cites W2197167222 @default.
• W2890762462 cites W2280099094 @default.
• W2890762462 cites W2299181842 @default.
• W2890762462 cites W2463432841 @default.
• W2890762462 cites W2503407514 @default.
• W2890762462 cites W2511766283 @default.
• W2890762462 cites W2530067632 @default.
• W2890762462 cites W2560185130 @default.
• W2890762462 cites W2572174216 @default.
• W2890762462 cites W2766762285 @default.
• W2890762462 cites W2767551096 @default.
• W2890762462 cites W2804073610 @default.
• W2890762462 cites W4251207193 @default.
• W2890762462 doi "https://doi.org/10.1172/jci96268" @default.
• W2890762462 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6205399" @default.
• W2890762462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30188869" @default.
• W2890762462 hasPublicationYear "2018" @default.
• W2890762462 type Work @default.
• W2890762462 sameAs 2890762462 @default.
• W2890762462 citedByCount "246" @default.
• W2890762462 countsByYear W28907624622018 @default.
• W2890762462 countsByYear W28907624622019 @default.
• W2890762462 countsByYear W28907624622020 @default.
• W2890762462 countsByYear W28907624622021 @default.
• W2890762462 countsByYear W28907624622022 @default.
• W2890762462 countsByYear W28907624622023 @default.
• W2890762462 crossrefType "journal-article" @default.
• W2890762462 hasAuthorship W2890762462A5005203519 @default.
• W2890762462 hasAuthorship W2890762462A5005298592 @default.
• W2890762462 hasAuthorship W2890762462A5008753971 @default.
• W2890762462 hasAuthorship W2890762462A5015105154 @default.
• W2890762462 hasAuthorship W2890762462A5023083194 @default.
• W2890762462 hasAuthorship W2890762462A5024539248 @default.
• W2890762462 hasAuthorship W2890762462A5030756098 @default.
• W2890762462 hasAuthorship W2890762462A5034936114 @default.
• W2890762462 hasAuthorship W2890762462A5036532953 @default.
• W2890762462 hasAuthorship W2890762462A5050522406 @default.
• W2890762462 hasAuthorship W2890762462A5054336312 @default.
• W2890762462 hasAuthorship W2890762462A5056472340 @default.
• W2890762462 hasAuthorship W2890762462A5065861312 @default.
• W2890762462 hasAuthorship W2890762462A5066060808 @default.
• W2890762462 hasAuthorship W2890762462A5081616053 @default.
• W2890762462 hasAuthorship W2890762462A5083451488 @default.
• W2890762462 hasAuthorship W2890762462A5087385646 @default.
• W2890762462 hasAuthorship W2890762462A5089753814 @default.

• next